
Paradigm’s Kurt Mussina discusses why scale should drive operational efficiency, not consolidation into single-site studies.
This article discusses strategies for finding the best cultural fit for a biopharmaceutical company, and the positive impact it has on implementing a successful FSP model, driving efficiency and continuity.






